A renewed attempt to introduce federal legislation to provide terminally-ill patients with access to drugs prior to US Food and Drug Administration approval is proposed by Senator Sam Brownback (Republican, Kansas) and House of Representatives member Dianne Watson (Democrat, California). The move follows the refusal of the Supreme Court to allow campaigners to present their case. At present, the FDA can block access to drugs for several years and drugmakers fear litigation (Marketletters passim).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze